ID FRAS1_MOUSE Reviewed; 4010 AA. AC Q80T14; E9QPG9; Q80TC7; Q811H8; Q8BPZ4; DT 16-AUG-2004, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 24-JAN-2024, entry version 150. DE RecName: Full=Extracellular matrix organizing protein FRAS1 {ECO:0000303|PubMed:32333816}; DE Flags: Precursor; GN Name=Fras1 {ECO:0000312|MGI:MGI:2385368}; Synonyms=Kiaa1500; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], DEVELOPMENTAL STAGE, AND DISEASE. RC STRAIN=NMRI; TISSUE=Brain; RX PubMed=12766770; DOI=10.1038/ng1168; RA Vrontou S., Petrou P., Meyer B.I., Vassilis K., Galanopoulos K., Imai K., RA Yanagi M., Chowdhury K., Scambler P.J., Chalepakis G.; RT "Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed RT phenotype in mice."; RL Nat. Genet. 34:209-214(2003). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2283-4010. RC TISSUE=Brain; RX PubMed=12693553; DOI=10.1093/dnares/10.1.35; RA Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S., RA Nakajima D., Nagase T., Ohara O., Koga H.; RT "Prediction of the coding sequences of mouse homologues of KIAA gene: II. RT The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs RT identified by screening of terminal sequences of cDNA clones randomly RT sampled from size-fractionated libraries."; RL DNA Res. 10:35-48(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2646-4010. RC STRAIN=C57BL/6J; TISSUE=Eye; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3228-4010. RC STRAIN=FVB/N; TISSUE=Kidney; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND DISEASE. RX PubMed=12766769; DOI=10.1038/ng1142; RA McGregor L.K., Makela V., Darling S.M., Vrontou S., Chalepakis G., RA Roberts C., Smart N., Rutland P., Prescott N., Hopkins J., Bentley E., RA Shaw A., Roberts E., Mueller R., Jadeja S., Philip N., Nelson J., RA Francannet C., Perez-Aytes A., Megarbane A., Kerr B., Wainwright B., RA Woolf A.S., Winter R.M., Scambler P.J.; RT "Fraser syndrome and mouse blebbed phenotype caused by mutations in RT FRAS1/Fras1 encoding a putative extracellular matrix protein."; RL Nat. Genet. 34:203-208(2003). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Kidney; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [8] RP FUNCTION, DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE, AND DISEASE. RX PubMed=32333816; DOI=10.1111/ejn.14759; RA Kalpachidou T., Makrygiannis A.K., Pavlakis E., Stylianopoulou F., RA Chalepakis G., Stamatakis A.; RT "Behavioural effects of extracellular matrix protein Fras1 depletion in the RT mouse."; RL Eur. J. Neurosci. 53:3905-3919(2021). CC -!- FUNCTION: Involved in extracellular matrix organization CC (PubMed:32333816). Required for the regulation of epidermal-basement CC membrane adhesion responsible for proper organogenesis during embryonic CC development (PubMed:12766769). Involved in brain organization and CC function (PubMed:32333816). {ECO:0000269|PubMed:12766769, CC ECO:0000269|PubMed:32333816}. CC -!- INTERACTION: CC Q80T14; Q6NVD0: Frem2; NbExp=2; IntAct=EBI-15594303, EBI-15594269; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12766769, CC ECO:0000269|PubMed:32333816}; Single-pass type I membrane protein CC {ECO:0000305}; Extracellular side {ECO:0000269|PubMed:12766769, CC ECO:0000269|PubMed:32333816}. CC -!- DEVELOPMENTAL STAGE: Highly expressed in the apical ectodermal ridge of CC the limb buds from 10.5-12.5 dpc and expression was also detected in CC the interdigital spaces at 14.5 dpc. Found in cells just underlying the CC surface epithelium of the entire embryo and in the linings of the CC peritoneal cavity and dorsal aorta. At 12 dpc, detected in the CC mesonephric duct and in the lens (PubMed:12766769). Found in a linear CC fashion underlying the epidermis and the basal surface of other CC epithelia in embryos (PubMed:12766770). Found in meningeal and CC choroidal epidermal-basement membranes in embryos and neonates CC (PubMed:32333816). {ECO:0000269|PubMed:12766769, CC ECO:0000269|PubMed:12766770, ECO:0000269|PubMed:32333816}. CC -!- DOMAIN: The Calx-beta domains bind calcium with high affinity and CC undergo a major conformational shift upon binding. {ECO:0000250}. CC -!- DISEASE: Note=Defects in Fras1 are the cause of blebbed (bl) phenotype, CC which is characterized by blister formation, syndactyly, eyelid fusion CC and renal agenesis. Subepidermal blisters are predominantly formed in CC the head region around the eyes and at the distal part of the limbs. As CC development proceeds blisters that are initially transparent gradually CC become hemorrhagic and embryos die between 14.5 dpc and 16.5 dpc. CC {ECO:0000269|PubMed:12766769, ECO:0000269|PubMed:12766770, CC ECO:0000269|PubMed:32333816}. CC -!- DISRUPTION PHENOTYPE: Homozygous adult knockout mice display impaired CC performance in various types of learning and memory tasks as well as CC reduced anxiety. {ECO:0000269|PubMed:32333816}. CC -!- SIMILARITY: Belongs to the FRAS1 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAC34788.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305}; CC Sequence=BAC34788.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ489280; CAD33519.1; -; mRNA. DR EMBL; AC101391; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC121829; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC122007; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC151985; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AK122518; BAC65800.1; -; mRNA. DR EMBL; AK051850; BAC34788.1; ALT_SEQ; mRNA. DR EMBL; BC044881; AAH44881.1; -; mRNA. DR CCDS; CCDS19450.1; -. DR RefSeq; NP_780682.3; NM_175473.3. DR SMR; Q80T14; -. DR BioGRID; 231125; 1. DR CORUM; Q80T14; -. DR DIP; DIP-61242N; -. DR IntAct; Q80T14; 2. DR STRING; 10090.ENSMUSP00000043250; -. DR GlyConnect; 2307; 1 N-Linked glycan (1 site). DR GlyCosmos; Q80T14; 16 sites, 1 glycan. DR GlyGen; Q80T14; 16 sites, 1 N-linked glycan (1 site). DR iPTMnet; Q80T14; -. DR PhosphoSitePlus; Q80T14; -. DR SwissPalm; Q80T14; -. DR EPD; Q80T14; -. DR MaxQB; Q80T14; -. DR PaxDb; 10090-ENSMUSP00000043250; -. DR PeptideAtlas; Q80T14; -. DR ProteomicsDB; 267408; -. DR Antibodypedia; 2470; 46 antibodies from 10 providers. DR DNASU; 231470; -. DR Ensembl; ENSMUST00000036019.5; ENSMUSP00000043250.5; ENSMUSG00000034687.9. DR GeneID; 231470; -. DR KEGG; mmu:231470; -. DR UCSC; uc008yfk.1; mouse. DR AGR; MGI:2385368; -. DR CTD; 80144; -. DR MGI; MGI:2385368; Fras1. DR VEuPathDB; HostDB:ENSMUSG00000034687; -. DR eggNOG; KOG1025; Eukaryota. DR eggNOG; KOG1216; Eukaryota. DR eggNOG; KOG1306; Eukaryota. DR eggNOG; KOG3525; Eukaryota. DR eggNOG; KOG3597; Eukaryota. DR GeneTree; ENSGT00940000162130; -. DR HOGENOM; CLU_000244_0_0_1; -. DR InParanoid; Q80T14; -. DR OMA; NSGMRVQ; -. DR OrthoDB; 5470912at2759; -. DR PhylomeDB; Q80T14; -. DR TreeFam; TF316876; -. DR BioGRID-ORCS; 231470; 3 hits in 77 CRISPR screens. DR ChiTaRS; Fras1; mouse. DR PRO; PR:Q80T14; -. DR Proteomes; UP000000589; Chromosome 5. DR RNAct; Q80T14; Protein. DR Bgee; ENSMUSG00000034687; Expressed in fourth ventricle and 212 other cell types or tissues. DR GO; GO:0005604; C:basement membrane; IDA:BHF-UCL. DR GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central. DR GO; GO:0007154; P:cell communication; IEA:InterPro. DR GO; GO:0030326; P:embryonic limb morphogenesis; IMP:MGI. DR GO; GO:0003338; P:metanephros morphogenesis; IMP:MGI. DR GO; GO:0002009; P:morphogenesis of an epithelium; IMP:MGI. DR GO; GO:0015031; P:protein transport; IMP:MGI. DR GO; GO:0060021; P:roof of mouth development; IMP:MGI. DR GO; GO:0043588; P:skin development; IMP:MGI. DR CDD; cd00064; FU; 12. DR Gene3D; 2.60.40.2030; -; 5. DR Gene3D; 6.20.200.20; -; 5. DR Gene3D; 2.10.70.10; Complement Module, domain 1; 1. DR InterPro; IPR038081; CalX-like_sf. DR InterPro; IPR003644; Calx_beta. DR InterPro; IPR039005; CSPG_rpt. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR006212; Furin_repeat. DR InterPro; IPR009030; Growth_fac_rcpt_cys_sf. DR InterPro; IPR001007; VWF_dom. DR PANTHER; PTHR45739:SF1; EXTRACELLULAR MATRIX ORGANIZING PROTEIN FRAS1; 1. DR PANTHER; PTHR45739; MATRIX PROTEIN, PUTATIVE-RELATED; 1. DR Pfam; PF16184; Cadherin_3; 12. DR Pfam; PF03160; Calx-beta; 5. DR Pfam; PF00093; VWC; 5. DR SMART; SM00237; Calx_beta; 5. DR SMART; SM00181; EGF; 10. DR SMART; SM00261; FU; 14. DR SMART; SM00214; VWC; 6. DR SMART; SM00215; VWC_out; 3. DR SUPFAM; SSF141072; CalX-like; 5. DR SUPFAM; SSF57603; FnI-like domain; 6. DR SUPFAM; SSF57184; Growth factor receptor domain; 5. DR PROSITE; PS51854; CSPG; 12. DR PROSITE; PS01208; VWFC_1; 6. DR PROSITE; PS50184; VWFC_2; 6. DR Genevisible; Q80T14; MM. PE 1: Evidence at protein level; KW Calcium; Cell membrane; Glycoprotein; Membrane; Metal-binding; KW Phosphoprotein; Reference proteome; Repeat; Signal; Transmembrane; KW Transmembrane helix. FT SIGNAL 1..25 FT /evidence="ECO:0000255" FT CHAIN 26..4010 FT /note="Extracellular matrix organizing protein FRAS1" FT /id="PRO_0000010121" FT TOPO_DOM 26..3903 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 3904..3924 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 3925..4010 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 26..87 FT /note="VWFC 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00220" FT DOMAIN 92..152 FT /note="VWFC 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00220" FT DOMAIN 156..216 FT /note="VWFC 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00220" FT DOMAIN 218..278 FT /note="VWFC 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00220" FT DOMAIN 282..342 FT /note="VWFC 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00220" FT DOMAIN 358..416 FT /note="VWFC 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00220" FT REPEAT 408..459 FT /note="FU 1" FT REPEAT 461..504 FT /note="FU 2" FT REPEAT 506..552 FT /note="FU 3" FT REPEAT 554..598 FT /note="FU 4" FT REPEAT 601..646 FT /note="FU 5" FT REPEAT 648..704 FT /note="FU 6" FT REPEAT 707..752 FT /note="FU 7" FT REPEAT 754..799 FT /note="FU 8" FT REPEAT 802..851 FT /note="FU 9" FT REPEAT 853..899 FT /note="FU 10" FT REPEAT 902..947 FT /note="FU 11" FT REPEAT 951..996 FT /note="FU 12" FT REPEAT 998..1041 FT /note="FU 13" FT REPEAT 1045..1088 FT /note="FU 14" FT REPEAT 1101..1196 FT /note="CSPG 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 1216..1307 FT /note="CSPG 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 1328..1440 FT /note="CSPG 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 1465..1561 FT /note="CSPG 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 1597..1691 FT /note="CSPG 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 1712..1812 FT /note="CSPG 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 1834..1938 FT /note="CSPG 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 1959..2059 FT /note="CSPG 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 2080..2179 FT /note="CSPG 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 2201..2293 FT /note="CSPG 10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 2313..2406 FT /note="CSPG 11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT REPEAT 2441..2538 FT /note="CSPG 12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01201" FT DOMAIN 2545..2648 FT /note="Calx-beta 1" FT DOMAIN 2661..2772 FT /note="Calx-beta 2" FT DOMAIN 2786..2892 FT /note="Calx-beta 3" FT DOMAIN 2907..3009 FT /note="Calx-beta 4" FT DOMAIN 3027..3131 FT /note="Calx-beta 5" FT MOD_RES 343 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86XX4" FT CARBOHYD 727 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1094 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1107 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1506 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1779 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1950 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1980 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2565 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2666 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2684 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2910 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2987 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 3072 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 3220 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 3678 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 3877 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CONFLICT 22 FT /note="N -> H (in Ref. 1; CAD33519)" FT /evidence="ECO:0000305" FT CONFLICT 1026 FT /note="L -> F (in Ref. 1; CAD33519)" FT /evidence="ECO:0000305" FT CONFLICT 1063 FT /note="R -> Q (in Ref. 1; CAD33519)" FT /evidence="ECO:0000305" FT CONFLICT 1466 FT /note="P -> H (in Ref. 1; CAD33519)" FT /evidence="ECO:0000305" FT CONFLICT 2020 FT /note="N -> H (in Ref. 1; CAD33519)" FT /evidence="ECO:0000305" FT CONFLICT 2208 FT /note="R -> K (in Ref. 1; CAD33519)" FT /evidence="ECO:0000305" FT CONFLICT 2310 FT /note="V -> L (in Ref. 1; CAD33519 and 3; BAC65800)" FT /evidence="ECO:0000305" FT CONFLICT 2314 FT /note="R -> Q (in Ref. 1; CAD33519 and 3; BAC65800)" FT /evidence="ECO:0000305" FT CONFLICT 2623 FT /note="G -> S (in Ref. 1; CAD33519 and 3; BAC65800)" FT /evidence="ECO:0000305" FT CONFLICT 2646 FT /note="G -> W (in Ref. 4; BAC34788)" FT /evidence="ECO:0000305" FT CONFLICT 2664 FT /note="V -> I (in Ref. 1; CAD33519 and 3; BAC65800)" FT /evidence="ECO:0000305" FT CONFLICT 3135 FT /note="L -> P (in Ref. 1; CAD33519 and 3; BAC65800)" FT /evidence="ECO:0000305" FT CONFLICT 3172 FT /note="D -> G (in Ref. 4; BAC34788)" FT /evidence="ECO:0000305" FT CONFLICT 3383 FT /note="Q -> R (in Ref. 1; CAD33519, 3; BAC65800 and 5; FT AAH44881)" FT /evidence="ECO:0000305" FT CONFLICT 3395 FT /note="N -> D (in Ref. 1; CAD33519, 3; BAC65800 and 5; FT AAH44881)" FT /evidence="ECO:0000305" SQ SEQUENCE 4010 AA; 442369 MW; 7C1DDED1C8ACEC04 CRC64; MGVLKAWLGV ALALAEFAVL PNCEGACLYQ GSFLADATIW KPDSCQNCRC HGDIVICKPV VCKNPRCAFE KGEVLWIAPN QCCPQCAPRT PGSCHHEGKI HEHGTEWASA PCTVCSCTHG EVRCSHQQCT PLSCGPQELE FLAEGRCCPI CVGTGKPCSY DGHVFQDGED WQLSRCAKCV CRNGLTQCFA AQCQPLFCNQ DEIVVRVPGK CCSQCSARSC STAGQVYEHG EQWKEDACTL CMCDQGQVRC HKQVCPPLRC AKGQGRARHH GQCCEECATP DRSCSSGGVL RYQDEMWKGS ACEFCMCDQG QVTCQTGECA KVACALGEEL VHLEGKCCPE CISRNGYCIY EQKAETMSSS AREIKHVPDG EKWEEGPCKL CECREAQVTC YEPSCPPCPV ATLALVVKGQ CCPDCTPVHC HPDCLTCSHS PDHCDLCQDP TKLLQNGRCV HSCGLGFYQA GSLCLACQPQ CSTCTNGLEC SSCLPPLLMQ QGQCVSTCGD GFYQDHHSCA VCHESCAGCW GPTEKHCMAC RDPLQVLRDS SCENTCGNGF YNRQGTCVAC DQSCKSCGPS SPRCLSCAEK TILHDGKCIS ECPHGYYADS TGSCKVCHSS CASCSGPTAA HCIACIHPQT LRQGHCLPSC GEGFYPDHGI CEACHASCHT CVGPQPSHCT QCKKPEAGLL VEQHSGENVP YGKCVSRCGT HFYLESTGLC EVCHPSCLTC EGKSPHNCTG CESTHALLAG CCVSQCPETH FNLEGTCTEC HPSCRQCHGP LESDCVSCHP HLTLTSGHCK TSCKEEQFLN LVGYCADCHP LCQHCVANLQ DTGSICLKCQ HARHLLLGDH CVPECPPGHY KERGTCKTCH SSCRSCQNGG PFSCSSCDTG LVLTHIGTCS TACFPGHYLD DNQVCQPCNR HCRSCDSQGS CTSCRDPSKV LLFGECQYES CTPQYYLDIA TKTCKECDWS CNACTGPLRT DCLQCMDGYV LQDGVCVEQC SPQHYRDSGS CKRCDSHCVE CQGPHECTRC EEPFLLFQAQ CVQECGKGYF ADHAKHRCIA CPQGCLRCSH KDRCHLCDHS FFLKSGLCMP TCVPGFSGHS SNENCTDKMY TPSLHVNGSL TLGIGSMKPL DFSLLNIQHQ DGRVEDLLFH VVSTPTNGQL LLSRNGKEVQ LEKAGHFSWK DVNEKKVRFV HSKEKLRKGY FSLKISDQQF FSEPQLINIQ AFSTQAPYVL RNEVLHVSKG ERATITTQLL DIRDDDNPQD VVVNVLDPPL HGQLLQMPPA PAASIYQFHL DELSRGLLLY AHDGSDSTSD IIVFQANDGH SFQNILFHVK NIPKNDRALR LVTNSMVWVP EGGMLKITNR ILKAQAPGVR ADDIIYKITH SRPQFGEVVL LMNLPADSPA GPAEEGHHLP DGRMATPIST FTQQDIDDGV VWYRHLGAPT QSDSFRFQVS SATSAQEHLE SHMFNIAILP QAPEAPKLSL GTSLHMTARE DGLSVIQPQS LSFVKAESPS GKIIYNITVP LHPNQGIIEH RDRPHSPIQY FTQEDINQGQ IMYRPPVAPP HLQEIMAFSF AGLPESVKFY FTVSDGQHTS PEMALTIHLL HSDLQPPAFQ VKAPLLEVSP GGRTSLGLQL LVRDAQVVPE ELFFQLQKSP QHGMLVKYTA KSSVTMAAGD TFTYDEVERN VLQYVHDGSS AWEDSLEISV TDGLTVTTSE VKVEVSPSEN RGPRLAPGSS LSMTVASQHT AIITRSHLAY VDDSSSDPEI WIRLSSLPLY GVLFRSSGPD MDELSGDSNF TMEDINKKNI RYSAVFETDG HSVTDGFHFS VSDMDGNHVD NQVFTITVTP AENPPHIIAF ADLITVDEGG RAPLSLHHFF ATEDQDNLQD DAVIKLSALP KYGCIENTGT GDRFGPGANS ELEASFPIQD VLENYIYYFQ SVHESIEPTH DVFSFYVSDG SGRSEIHSIN ITIERKNDEP PRMTLRPLGV RLSSGVAISN SSLSLQDLDT PDNELIFVLM KKPDHGHLLR RSTASDPLEN GTVLDQGSSF TYQDVLAGLV GYLPGDIYMA VDEFRFSLTD GLHVDTGRME IYIELPSTNI PHLAINRGLQ LSAGSVARIT EQHLKATDTD SEAGQVVYIM KEDPGAGRLL MAKADNLEQI SVRGPIRSFT QADVSQGQIE YSHGPGEPGG SFAFKFDVVD GEGNKLADQS FSIGVLEDKS PPVVITNRGL VLDENSVEKI TTAQLSATDQ DSKPTELIYR ITTQPQLGHL EHVASPGIQI SSFTQADLAS RNVQYVRSSG TGKQSDAFSF VLSDGLHEVT QTFPITIHPV DDARPLVQNR GMRVQEGVRK TITEFELKAV DVDTEAESIT FTIVQPPRHG TIERTARGQR FHQTSSFTME DIYQNRVSYS HDGSNSLKDR FTFTVSDGTN PFFIIEEGGE EIMTAAPQQF HVDILPVDDG TPRIVTNLGL QWLEYMDGKA TNLITKKELL TVDPDTEDSQ LIYEVTTGPM HGYLENKLQP GRAAATFTQE HVNLGLIRYV LYEEKIQKVM DSFQFLVKDS KPNVVSDNVF HIQWSLISFK YTSYNVSEKA GSVSVTVQRT GNLNQYAIVL CRTEQGTASS SSHPGQQDYM EYAGQVQFDE GEGTKSCTVI INDDDVFENI ESFTVGLSMP AYALLGEFTQ AKVVINDTED EPTLEFDKKT YRVNESAGFL FAPIKRQGDS SSTVSAVCYT VPKSAMGSSL YALESGSDFK SRGRSAESRV IFGPGVTVST CDVMVIDDSE YEEEEEFEIA LADASNNARI GRQAVAKVLI SGPNDASTVS LGNTAFTISE DAGTVKIPVI RHGTDLSTFT SVWCATRPSD PASATPGVDY VPSSRKVEFG PGITEQYCTL TILDDTQYPV IEGLETFVVF LSSAQGAELT KPSQAVIAIN DTFQDVPSMQ FSKDLLLVKE KEGVLHIPII RSGDLSYESS VRCYTQGHSA QVMEDFEERR NADSSRITFL KGQKTKNCTV YIHDDSMFEP EEQFRVYLGH PLGNHWSGAR IGKNSVATVT ISNDEDAPTI EFEEAAYQVR EPAGPEAIAV LSIKVIRRGD QNRTSKIRCS TRDGSAQSGV DYYPKSRVLK FSPGVDHIFF KVEILSNEDR EWHESFSLVL GPDDLVEAVL GDVTTATVTI LDQEAAGSLI LPAPPIVVTL ADYDHVEELA KEGVKKAPSP GYPLVCVTPC DPRYPRYAVM KERCSEAGIN QTSVQFSWEV AAPTDGNGAR SPFETITDNT PFTSVNHKVL DSIYFSRRFH VRCVAKAVDK VGHVGTPLRS NVVTIGTDSA ICHTPVVAGT ARGFQAQSFI ATLKYLDVKH KEHPNRIHIS VQIPHQDGML PLISTMPLHN LHFLLSESIY RHQHVCSNLV TAQDLRGLAE AGFLNDAGFH STALGPGYDR PFQFDSSVRE PKTIQLYRHL NLKSCVWTFD AYYDMTELID VCGGSVTADF QVRDSAQSFL TVHVPLYVSY IYVTAPRGWA SLEHHTEMEF SFFYDTVLWR TGIQTDSVLS ARLQIIRIYI REDGRLVIEF KTHAKFRGQF VIEHHTLPDV KSFILTPDHL GGIQFDLQLL WSAQTFDSPH QLWRATSSYN RKDYSGEYTI YLIPCTVQPT QPWVDPGEKA LACTAHAPER FLIPIAFQQT NRPVPVVYSL NTEFQLCNNE KVFLMDPNTS DMSLAEMDYK GAFSKGQILY GRVLWNPEQN LHSAYKLQLE KVYLCTGKDG YVPFFDPTGT IYNEGPQYGC IQPNKHLKHR FLLLDRSQPE VTDKYFHDVP FEAHFASELP DFQVVSSMPG VDGFTLKVDA LYKVEAGHQW YLQVIYIIGP DSTSRPRVQR SLTVSLRRHQ RDLVDPSGWL SLDDSLIYDN EGDQVKNGTN MKSLNLEMQE PVIAASLSQT GASIGSALAA IMLLLLLFLV ACFVTRKCQK QKKKQPPEDT LEEYPLNTKV DVAKRNADKV EKNANRQYCT VRNVNILSDN EGYYTFKGAK VKKLNLEVRV HNNLQDGTEV //